|
Mr. D'Alonzo joined the Board of Directors of Salix in May 2000 with over 17 years of pharmaceutical executive experience. From 1996 to 1999, Mr. D'Alonzo served as President and Chief Operating Officer of Pharmaceutical Product Development, Inc. ("PPD"), a publicly traded research, development and consulting services in life and discovery sciences company with over 3,000 employees worldwide. Before joining PPD, he served as President and Chief Executive Officer of GENVEC, Inc. (gene therapy biotech) from 1993 to 1996. From 1983 to 1993, Mr. D'Alonzo held positions of increasing responsibility within Glaxo Inc., including President of Glaxo, Inc. Mr. D'Alonzo is a director of Amarillo Biosciences, Inc., a publicly traded company. Mr. D'Alonzo also serves on the boards of two private biotech companies; Bio-Informatics Group Inc. and Dara BioSciences, Inc. (a biopharmaceuticals company). Mr. D'Alonzo received his B.S. degree in Business Administration from the University of Delaware, and his law degree from the University of Denver College of Law. | 